Jan 10, 2024 / 11:45PM GMT
Rohan Patel JPMorgan Chase&Co.-Analyst
Hi, everyone. My name is Rohan Patel. I work on the medical devices and research team at JPMorgan. I just want to say, it's my pleasure to introduce our CEO, Nadim Yared of CVRx to provide his opening remarks.
Nadim Yared - CVRx Inc - President, Chief Executive Officer, Director
Thank you, Rohan and thanks, JPMorgan, for the opportunity here to speak. It's been a couple of years and here in a row, but this is the first time we're sitting at the adult stable and the speaker room. We said, a bit impressive, thank you, Rohan.
Forward looking statements -- and we're here to talk about CVRx. It's a great company. We'll be talking about the product about the technology and but we're only limited to 20 minutes of slides to go as fast as possible, slight shrinkage even further. So as we get an answer more questions toward the end. So be ready with your questions.
Our company CVRx developed the first FDA approved neuro modulation device that is addressing a cardiovascular disease. We
CVRx Inc at JPMorgan Healthcare Conference Transcript
Jan 11, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers